|
Report Date : |
12.06.2013 |
IDENTIFICATION DETAILS
|
Name : |
KUK JEON PHARM. CO., LTD. |
|
|
|
|
Registered Office : |
810, Gwanyang-dong, Dongan-gu, Anyang-si, Gyeonggi-do, Korea 431-810 |
|
|
|
|
Country : |
South Korea |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
26.07.1995 |
|
|
|
|
Com. Reg. No.: |
208-81-25074 |
|
|
|
|
Legal Form : |
Co., Ltd by shares |
|
|
|
|
Line of Business : |
Wholesale of Other Chemical Materials and Chemical Products |
|
|
|
|
No. of Employees : |
64 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
South Korea |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
south Korea - ECONOMIC OVERVIEW
South Korea over the past four decades has demonstrated
incredible growth and global integration to become a high-tech industrialized
economy. In the 1960s, GDP per capita was comparable with levels in the poorer
countries of Africa and Asia. In 2004, South Korea joined the trillion dollar
club of world economies, and is currently the world''s 12th largest economy.
Initially, a system of close government and business ties, including directed
credit and import restrictions, made this success possible. The government
promoted the import of raw materials and technology at the expense of consumer
goods, and encouraged savings and investment over consumption. The Asian
financial crisis of 1997-98 exposed longstanding weaknesses in South Korea''s
development model including high debt/equity ratios and massive short-term
foreign borrowing. GDP plunged by 6.9% in 1998, and then recovered by 9% in
1999-2000. Korea adopted numerous economic reforms following the crisis,
including greater openness to foreign investment and imports. Growth moderated
to about 4% annually between 2003 and 2007. Korea''s export focused economy was
hit hard by the 2008 global economic downturn, but quickly rebounded in
subsequent years, reaching 6.3% growth in 2010. The US-South Korea Free Trade
Agreement was ratified by both governments in 2011 and went into effect in
March 2012. Throughout 2012 the economy experienced sluggish growth because of
market slowdowns in the United States, China, and the Eurozone. The incoming
administration in 2013, following the December 2012 presidential election, is
likely to face the challenges of balancing heavy reliance on exports with
developing domestic-oriented sectors, such as services. The South Korean
economy''s long term challenges include a rapidly aging population, inflexible
labor market, and heavy reliance on exports - which comprise half of GDP.
|
Source
: CIA |
Basic
|
Company Name |
KUK JEON PHARM. CO., LTD. |
|
Registered Address |
810, Gwanyang-dong, Dongan-gu, Anyang-si, Gyeonggi-do, Korea |
|
Zip Code |
431-810 |
|
Tel |
+82-31-352-8129 |
|
Fax |
+82-31-352-8176 |
|
E-mail |
hjh1215@kukjeon.co.kr;pharm@kukjeon.co.kr;antibox@kukjeon.co.kr |
|
Website |
www.kukjeon.co.kr |
|
Trading Address |
810, Gwanyang-dong, Dongan-gu, Anyang-si, Gyeonggi-do, Korea (New Address System : 282, Hagui-ro, Dongan-gu, Anyang-si,
Gyeonggi-do, Korea) |
|
Tel |
+82-31-352-8039 |
|
Fax |
+82-31-352-8230 |
|
Other Address-Paltan Branch |
542-8, Samcheonbyeongma-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do,
Korea |
|
Other Address-Hwaseong Branch |
8, Barangongdan-ro, Hyangnam-eup,
Hwaseong-si, Gyeonggi-do, Korea |
|
Other Address-Seoul Office |
Rm.1015, 72, Mareunnae-ro, Jung-gu, Seoul,
Korea |
|
Tel |
+82-2-3486-2246 |
|
Fax |
+82-2-3486-2283 |
|
Type |
Export/Import |
|
Industry |
Wholesale of Other Chemical Materials and Chemical Products |
|
Main Business |
Pharmaceutical Raw Materials |
|
Established (mm/dd/yyyy) |
07/26/1995 |
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Indicators and Reagents(12161500) |
|
Name |
Hong Jong-Ho |
|
Address |
Suite 112-801, 10, Seokgwan-dong,
Seongbuk-gu, Seoul, Korea |
|
Date of Birth |
12/15/1971 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
|
Capital (KRW) |
1,350,000,000 |
||||||||||||||||||
|
Employees |
64 |
||||||||||||||||||
|
Formation |
Co., Ltd by shares |
||||||||||||||||||
|
Bank Details |
Shinhan Bank-Jongno 5Ga Branch Woori Bank-Jongro 6Ga Branch |
||||||||||||||||||
|
Corporate Registered No. |
110111-1181140 |
||||||||||||||||||
|
Business Registered No. |
208-81-25074 |
||||||||||||||||||
|
Permit & Licenses |
Int’l Trade No.: 11553663 |
||||||||||||||||||
|
Shareholder Position |
|
||||||||||||||||||
|
Company History |
07/26/1995 Incorporated as the present name 06/03/2008 Increased capital to
1,350,000,000 KRW from 1,150,000,000 KRW 08/20/2012 Moved to the present HQ address
from Rm.101,
Boram Bldg., 954-17, Bangbae-dong, Seocho-gu, Seoul, Korea |
||||||||||||||||||
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Date |
|
President & CEO |
Mr. |
Hong Jong-Ho |
Male |
Korean |
05/20/2008 |
|
Director |
M/S. |
Shim Soon-Sun |
Female |
Korean |
08/20/1998 |
|
Director |
Mr. |
Cho Doo-Hyun |
Male |
Korean |
03/29/2012 |
|
Auditor |
Mr. |
Hong Jong-Hoon |
Male |
Korean |
08/09/1995 |
Financials
|
Year / Unit : KRW |
Sales |
Assets |
Net Income |
|
35,165,534,590 |
25,312,649,796 |
981,885,557 |
|
|
2011 |
26,166,511,170 |
16,085,706,036 |
1,694,343,494 |
|
2010 |
|
|
|
|
2009 |
|
|
530,330,000 |
|
2008 |
|
|
347,130,000 |
|
2007 |
|
|
306,140,000 |
|
2006 |
7,144,000,000 |
3,329,000,000 |
267,090,000 |
|
2005 |
5,371,000,000 |
3,504,000,000 |
70,000,000 |
|
2004 |
|
|
|
|
2003 |
|
|
|
|
Authorized Capital(KRW) |
4,000,000,000 |
|
Paid-Up Capital(KRW) |
1,350,000,000 |
|
Total Issues Shares |
135,000 |
|
Balance Sheet |
|||
|
Unit : Korean Won |
As of 12/31/2012 |
As of 12/31/2011 |
As of 12/31/2010 |
|
Total Assets |
25,312,649,796 |
16,085,706,036 |
|
|
Current Assets |
12,531,360,179 |
10,311,494,371 |
|
|
-Quick Assets |
8,272,990,383 |
8,005,715,617 |
|
|
-Inventories |
4,258,369,796 |
2,305,778,754 |
|
|
Fixed Assets |
12,781,289,617 |
5,774,211,665 |
|
|
-Investment |
700,207,650 |
255,000,000 |
|
|
-Tangibles |
10,941,590,887 |
4,998,351,392 |
|
|
-Intangibles |
2,041,916 |
212,000 |
|
|
-Others |
1,137,449,164 |
520,648,273 |
|
|
Total Liabilities |
19,660,486,102 |
11,415,427,899 |
|
|
Current Liabilities |
7,975,480,601 |
5,312,321,398 |
|
|
Fixed Liabilities |
11,685,005,501 |
6,103,106,501 |
|
|
Capital Stock |
1,350,000,000 |
1,350,000,000 |
|
|
Capital Surplus |
- |
- |
|
|
Profit Surplus |
4,302,163,694 |
3,320,278,137 |
|
|
Capital Adjustment |
- |
- |
|
|
Total Equity |
5,652,163,694 |
4,670,278,137 |
|
|
Liab. & Shareholder’s Equity |
25,312,649,796 |
16,085,706,036 |
|
|
Current Liabilities |
7,975,480,601 |
5,312,321,398 |
|
|
Trade Payables |
3,598,774,122 |
3,440,762,519 |
|
|
Account Payables |
743,797,725 |
470,997,814 |
|
|
Withholdings |
47,743,036 |
40,009,286 |
|
|
VAT Withhold |
- |
1,907,619 |
|
|
Advance Receipts |
321,782,740 |
91,388,330 |
|
|
Accrued Expenses |
62,762,968 |
- |
|
|
Deferred Income Tax |
25,590,010 |
127,255,830 |
|
|
Short-Term Borrowings |
3,000,000,000 |
990,000,000 |
|
|
Current Portion of Long-Term Debts |
175,030,000 |
150,000,000 |
|
|
Fixed Liabilities |
11,685,005,501 |
6,103,106,501 |
|
|
Debentures |
2,000,000,000 |
2,000,000,000 |
|
|
Long-Term Borrowings |
8,556,899,000 |
2,975,000,000 |
|
|
Leasehold Deposit Received |
65,000,000 |
65,000,000 |
|
|
Provision for Severance & Retirement |
1,063,106,501 |
1,063,106,501 |
|
|
Income Statement |
|||
|
Unit : Korean Won |
As of 12/31/2012 |
As of 12/31/2011 |
As of 12/31/2010 |
|
Sales |
35,165,534,590 |
26,166,511,170 |
|
|
Cost of Sold Goods |
29,461,925,422 |
21,138,189,530 |
|
|
Gross Profit |
5,703,609,168 |
5,028,321,640 |
|
|
Selling & Admin. Expenses |
4,010,180,034 |
3,078,325,244 |
|
|
Operating Income |
1,693,429,134 |
1,949,996,396 |
|
|
Non-Operating Income |
304,633,746 |
122,252,438 |
|
|
Non-Operating Expenses |
782,651,790 |
224,942,168 |
|
|
Income Before Taxes |
1,215,411,090 |
1,847,306,666 |
|
|
Income Taxes Expenses |
233,525,533 |
152,963,172 |
|
|
Net Income |
981,885,557 |
1,694,343,494 |
|
|
Cash Flows |
|||
|
Unit : Korean Won |
As of 12/31/2012 |
As of 12/31/2011 |
As of 12/31/2010 |
|
Cash Flows from Operating |
-560,339,028 |
-555,968,600 |
|
|
-Net Income |
981,885,557 |
1,694,343,494 |
|
|
-Exp. without Cash Outflow |
596,406,029 |
484,045,657 |
|
|
-Revenue without Cash Inflows |
-45,707,632 |
- |
|
|
-Changes in Asset/ & Liability |
-2,092,922,982 |
-2,734,357,751 |
|
|
Cash Flows from Investing |
-7,052,620,833 |
-2,824,389,176 |
|
|
-Cash Inflow from Investing |
358,495,295 |
2,711,447,990 |
|
|
-Cash Outflows for Investing |
-7,411,116,128 |
-5,535,837,166 |
|
|
Cash Flows from Financing |
7,616,929,000 |
3,208,632,000 |
|
|
-Cash Inflows from Financing |
8,756,929,000 |
6,390,000,000 |
|
|
-Cash Outflows from Financing |
-1,140,000,000 |
-3,181,368,000 |
|
|
Increase/Decrease in Cash |
3,969,139 |
-171,725,776 |
|
|
Cash at the Beginning of Year |
256,860,225 |
428,586,001 |
|
|
Cash at the End of Year |
260,829,364 |
256,860,225 |
|
|
Main Products & Services |
Pharmaceutical Raw Materials |
|
Detailed Products Spec. |
|
|
Technologies Acquired |
|
|
Suppliers |
|
|
Customers |
Domestic, Hospitals, pharmacies,
pharmaceutical companies, pharmaceutical wholesalers etc. |
|
Competitors |
ASAN PHARMACEUTICAL CO., LTD. 73, YEONGCHEON-RI, DONGTAN-MYEON,
HWASEONG-SI, GYEONGGI-DO, KOREA TEL:+82-31-376-5990 FAX:+82-31-376-5993 SAMCHUN PURE CHEMICAL CO., LTD. 10B-5L, SONGTAN INDUSTRIAL COMPLEX, 440-3,
MOGOK-DONG, PYEONGTAEK-SI, GYEONGGI-DO, KOREA TEL:+82-31-668-0700~4 FAX:+82-31-665-7482 BLUEWAVE CORPORATION 501-22, BYUCKSAN GRAND CORE, 1125-2,
INGYE-DONG, PALDAL-GU, SUWON-SI, GYEONGGI-DO, KOREA TEL:+82-31-239-8004 FAX:+82-31-239-8006 |
|
Affiliates |
|
|
Overseas Office |
|
|
Liaison Office |
|
|
Overseas Branch |
|
|
Joint Venture |
|
|
Subsidiary |
|
|
Corporate Ownership |
|
|
Major Shareholders |
|
|
Cooperative Enterprise |
-Insured Company HANWHA GENERAL INSURANCE CO., LTD.(110111-0006456) SAMSUNG FIRE & MARINE INSURANCE CO., LTD.(110111-0005078) |
Not Available.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.58.92 |
|
|
1 |
Rs.91.80 |
|
Euro |
1 |
Rs.78.18 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.